Search for: "Teva Pharmaceuticals"
Results 601 - 620
of 1,424
Sort by Relevance
|
Sort by Date
2 Dec 2014, 12:27 pm
Supreme Court heard argument six weeks ago in Teva Pharmaceuticals USA v. [read post]
21 Nov 2014, 4:00 am
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
30 Oct 2014, 12:02 pm
“Some of the biggest generic drug companies — Mylan, Actavis and Teva Pharmaceutical Industries — have been aggressively snapping up other manufacturers in recent years,” Lazarus wrote, “reducing the number of players in the market. [read post]
30 Oct 2014, 11:34 am
Note Reuters post Teva optimistic U.S. top court to rule in favor of MS drug patent with textTeva Pharmaceutical Industries is optimistic the U.S. [read post]
27 Oct 2014, 5:27 am
* Obviousness, common general knowledge and expectations of success: Leo gets a mauling Jeremy hosts this post by Suleman Ali (Holly IP) on Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat), a decision by Mr Justice Birss in the Patents Court, England and Wales which addresses two patent law cornerstones: obviousness and common general knowledge. [read post]
21 Oct 2014, 9:03 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
21 Oct 2014, 12:00 am
The author is occasional and much-appreciated guest contributor Suleman Ali (Holly IP), who writes as follows:Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited[2014] EWHC 3096 (Pat) is a decision by Mr Justice Birss in the Patents Court, England and Wales. [read post]
20 Oct 2014, 10:00 pm
Teva Pharmaceuticals, USA, Inc. [read post]
20 Oct 2014, 12:09 pm
On October 15, 2014, the Supreme Court heard oral argument inTeva Pharmaceuticals USA, Inc. v. [read post]
17 Oct 2014, 5:09 pm
Stephens Teva Pharmaceuticals USA, Inc., v. [read post]
17 Oct 2014, 7:23 am
At Bloomberg View, Noah Feldman analyzes Wednesday’s oral argument in the patent case Teva Pharmaceuticals USA v. [read post]
17 Oct 2014, 12:00 am
On October 15, 2014, the Supreme Court heard arguments on the case of Teva Pharmaceuticals v. [read post]
16 Oct 2014, 7:10 am
In Teva Pharmaceuticals USA, Inc. v. [read post]
16 Oct 2014, 3:12 am
Yesterday the Court heard oral arguments in the patent procedure case Teva Pharmaceuticals USA v. [read post]
15 Oct 2014, 2:49 pm
Teva Pharmaceutical Industries Ltd. got a mixed reception at a U.S. [read post]
15 Oct 2014, 2:32 pm
The transcript in Teva Pharmaceuticals USA v. [read post]
15 Oct 2014, 11:52 am
Supreme Court oral argument in Teva Pharmaceuticals USA, Inc. v. [read post]
15 Oct 2014, 10:30 am
That was the dilemma that appeared to emerge as the Justices heard one of the biggest patent cases in years, Teva Pharmaceuticals USA v. [read post]
